IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,601,196 | +61626.9% | 39,025 | -46.2% | 0.02% | -52.5% |
| Q1 2023 | $2,594 | +88.8% | 72,577 | +99.6% | 0.04% | +48.1% |
| Q4 2022 | $1,374 | -99.9% | 36,365 | +72.3% | 0.03% | +35.0% |
| Q3 2022 | $934,000 | -66.0% | 21,109 | -71.5% | 0.02% | -72.2% |
| Q2 2022 | $2,747,000 | +151.1% | 74,192 | +151.3% | 0.07% | +176.9% |
| Q1 2022 | $1,094,000 | -79.8% | 29,525 | -83.4% | 0.03% | -71.4% |
| Q4 2021 | $5,428,000 | -19.7% | 178,386 | -11.5% | 0.09% | -17.3% |
| Q3 2021 | $6,762,000 | +69.7% | 201,613 | +101.8% | 0.11% | +46.7% |
| Q2 2021 | $3,984,000 | +88.1% | 99,886 | +123.7% | 0.08% | -18.5% |
| Q3 2020 | $2,118,000 | +287.9% | 44,644 | +286.7% | 0.09% | +87.8% |
| Q1 2020 | $546,000 | -41.7% | 11,546 | -20.8% | 0.05% | +81.5% |
| Q2 2019 | $937,000 | +354.9% | 14,576 | +475.2% | 0.03% | +200.0% |
| Q1 2019 | $206,000 | -71.0% | 2,534 | -80.7% | 0.01% | -35.7% |
| Q4 2018 | $710,000 | +234.9% | 13,135 | +44.3% | 0.01% | +250.0% |
| Q2 2016 | $212,000 | – | 9,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,136 | $133,749 | 7.12% |
| Bellevue Group AG | 9,743,900 | $368,027,103 | 4.88% |
| M28 Capital Management LP | 126,300 | $4,770,351 | 4.55% |
| Sicart Associates LLC | 246,258 | $9,301,165 | 3.28% |
| Camber Capital Management LP | 1,925,000 | $72,707 | 2.49% |
| Privium Fund Management B.V. | 148,807 | $5,557,941 | 2.11% |
| Deep Track Capital, LP | 1,205,773 | $45,542,046 | 1.91% |
| BVF INC/IL | 1,121,809 | $42,370,726 | 1.79% |
| Orbimed Advisors | 1,993,600 | $75,298,272 | 1.44% |
| Parkman Healthcare Partners LLC | 141,115 | $5,329,914 | 1.42% |